WW45 inhibits breast cancer cell proliferation by the Hedgehog signaling pathway

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• WW45 is a novel tumor suppressor gene with unclear mechanisms in breast cancer proliferation.
• The role of upstream proteins in regulating Gli1 nuclear import, a key transcription factor in the Hedgehog signaling pathway, remains largely unknown.

Purpose of the Study:

• To elucidate the molecular mechanism by which WW45 inhibits breast cancer cell proliferation.
• To investigate the interaction between WW45 and Gli1 and its impact on cancer cell growth.

Main Methods:

• Western blot analysis to detect WW45 and Gli1 expression in breast cancer cell lines.
• Co-immunoprecipitation assays to determine physical interaction between WW45 and Gli1.
• Cellular functional experiments to assess growth inhibition and colony formation.

Main Results:

• WW45 overexpression significantly reduced proliferation and colony formation in breast cancer cells.
• A negative correlation was observed between WW45 and Gli1 expression levels in breast cancer.
• WW45 directly interacts with Gli1, influencing its intracellular localization via WW-PPxY/PsP interaction.
• Gli1 was found to counteract WW45-mediated growth inhibition.

Conclusions:

• WW45 acts as a tumor suppressor in breast cancer by negatively regulating the Hedgehog signaling pathway component Gli1.
• The physical interaction between WW45 and Gli1 is crucial for controlling Gli1's function and WW45's tumor-suppressive activity.
• Targeting the WW45-Gli1 interaction may offer a novel therapeutic strategy for breast cancer.